Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides

Int J Dermatol. 2007 Apr;46(4):435-8. doi: 10.1111/j.1365-4632.2007.03221.x.

Abstract

Mycosis fungoides (MF), a cutaneous T-cell lymphoma, is usually characterized by cell features of T-helper-2 (Th2) lymphocytes. MF has recently been reported to show increased CCR4 expression, a chemokine receptor specifically expressed in Th2. Previously, we have reported the effectiveness of interferon-gamma (IFN-gamma) for the treatment of CCR4(+) MF. In this report, we describe two cases of CD4(+), CCR4(-) MF successfully treated with IFN-alpha, but not IFN-gamma. Although MF usually displays a Th2 profile, the tumor cells in our two cases did not express CCR4. Our cases suggest the effectiveness of IFN-alpha, but not IFN-gamma, for CCR4- MF.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • CD4-Positive T-Lymphocytes / metabolism
  • Diagnosis, Differential
  • Erythema / etiology
  • Humans
  • Injections, Subcutaneous
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle Aged
  • Mycosis Fungoides / blood
  • Mycosis Fungoides / complications
  • Mycosis Fungoides / diagnosis*
  • Mycosis Fungoides / drug therapy*
  • Mycosis Fungoides / metabolism
  • Mycosis Fungoides / pathology
  • Receptors, CCR4
  • Receptors, Chemokine / metabolism

Substances

  • Antineoplastic Agents
  • CCR4 protein, human
  • Interferon-alpha
  • Receptors, CCR4
  • Receptors, Chemokine